PL4055191T4 - Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi - Google Patents

Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi

Info

Publication number
PL4055191T4
PL4055191T4 PL20800688.2T PL20800688T PL4055191T4 PL 4055191 T4 PL4055191 T4 PL 4055191T4 PL 20800688 T PL20800688 T PL 20800688T PL 4055191 T4 PL4055191 T4 PL 4055191T4
Authority
PL
Poland
Prior art keywords
biomarkers
blood
bipolar disorder
differential diagnosis
depressive disorders
Prior art date
Application number
PL20800688.2T
Other languages
English (en)
Other versions
PL4055191T3 (pl
Inventor
Dinah Weissmann
Nicolas Salvetat
Fabrice Chimienti
Original Assignee
Alcediag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcediag filed Critical Alcediag
Publication of PL4055191T3 publication Critical patent/PL4055191T3/pl
Publication of PL4055191T4 publication Critical patent/PL4055191T4/pl

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/165Mathematical modelling, e.g. logarithm, ratio
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Microbiology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL20800688.2T 2019-11-08 2020-11-09 Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi PL4055191T4 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19208126.3A EP3819387A1 (en) 2019-11-08 2019-11-08 Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers
PCT/EP2020/081459 WO2021089866A1 (en) 2019-11-08 2020-11-09 Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers

Publications (2)

Publication Number Publication Date
PL4055191T3 PL4055191T3 (pl) 2024-12-16
PL4055191T4 true PL4055191T4 (pl) 2024-12-16

Family

ID=68501512

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20800688.2T PL4055191T4 (pl) 2019-11-08 2020-11-09 Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi

Country Status (10)

Country Link
US (1) US20230272472A1 (pl)
EP (2) EP3819387A1 (pl)
JP (1) JP2023500847A (pl)
KR (1) KR20220094201A (pl)
CN (1) CN114945686A (pl)
CA (1) CA3155693A1 (pl)
ES (1) ES2992208T3 (pl)
IL (1) IL292588A (pl)
PL (1) PL4055191T4 (pl)
WO (1) WO2021089866A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3819386A1 (en) * 2019-11-08 2021-05-12 Alcediag Diagnosing of mood disorders using blood rna editing biomarkers
CN113604583B (zh) * 2021-08-10 2024-04-02 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒
US20260053406A1 (en) * 2022-08-14 2026-02-26 Carmel Haifa University Economic Corporation Ltd. System and method of predicting disposition of a mental disorder of a subject
KR102808802B1 (ko) * 2022-09-02 2025-05-21 주식회사 비욘드디엑스 우울증과 양극성 장애 구분용 바이오마커 및 이의 용도
EP4389915A1 (en) 2022-12-21 2024-06-26 Alcediag Differential diagnosing of bipolar versus unipolar disorder in patient during depression phases using a to i rna editing znf267 gene
CN120883057A (zh) * 2024-02-29 2025-10-31 百越达析 用于区分抑郁症和双相情感障碍的生物标志物及其用途
WO2025233372A1 (en) * 2024-05-06 2025-11-13 Alcediag Method for differentiating patients across healthy control, bipolar disorder, schizophrenia, and schizoaffective groups
CN121041412A (zh) * 2024-05-30 2025-12-02 上海交通大学 细胞因子cxcl10在抑郁和/或焦虑障碍中的应用
CN119724545B (zh) * 2024-12-05 2025-09-23 南京利康医药科技有限公司 一种基于靶向代谢组学和机器学习模型的抑郁症疾病管理系统
CN119662807B (zh) * 2025-01-14 2025-11-28 江南大学 肺炎支原体肺炎感染重症度及并发症标记物及其在制备肺炎支原体感染诊断试剂盒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1766077T3 (da) * 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
WO2008066769A2 (en) * 2006-11-29 2008-06-05 Lohocla Research Corporation Genetic diagnosis of depression
EP2162550B1 (en) * 2007-06-13 2017-08-09 Alcediag Peripherical tissue sample containing cells expressing the 5htr2c and/or adars as markers of the alteration of the mechanism of the 5htr2c mrna editing and its applications
CN108779494B (zh) * 2016-03-11 2024-05-14 阿利瑟迪亚格公司 选择由活性化合物诱导的特定效应的基于rna编辑的算法和体外方法
US11104953B2 (en) * 2016-05-13 2021-08-31 Children's Hospital Medical Center Septic shock endotyping strategy and mortality risk for clinical application
AU2017302132A1 (en) * 2016-07-28 2019-02-21 Alcediag RNA editing as biomarkers for mood disorders test
EP3819386A1 (en) * 2019-11-08 2021-05-12 Alcediag Diagnosing of mood disorders using blood rna editing biomarkers

Also Published As

Publication number Publication date
KR20220094201A (ko) 2022-07-05
ES2992208T3 (es) 2024-12-10
EP4055191C0 (en) 2024-07-03
EP3819387A1 (en) 2021-05-12
CN114945686A (zh) 2022-08-26
JP2023500847A (ja) 2023-01-11
WO2021089866A1 (en) 2021-05-14
PL4055191T3 (pl) 2024-12-16
EP4055191B1 (en) 2024-07-03
US20230272472A1 (en) 2023-08-31
EP4055191A1 (en) 2022-09-14
CA3155693A1 (en) 2021-05-14
IL292588A (en) 2022-06-01

Similar Documents

Publication Publication Date Title
PL4055191T4 (pl) Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi
PL4055190T4 (pl) Diagnozowanie zaburzeń nastroju za pomocą biomarkerów edycji rna we krwi
IL282233A (en) Nucleic acid constructs and methods of use
UY33826A (es) Proteínas de unión con dominios trivariables y sus usos
HRP20260212T1 (hr) Pripravci i postupci za liječenje mišićne distrofije
IL283149A (en) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer
IL261002A (en) Vcn enhancer compositions and methods of using the same
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
MA43980A (fr) Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires
EP3921445A4 (en) DETECTION OF CANCER, ORIGIN CANCER TISSUE, AND/OR A CANCER CELL TYPE
EP3411505A4 (en) EVIDENCE OF CANCER DEVELOPMENT AND DIAGNOSTICS
IL286481A (en) Pyridazinones and methods of use thereof
EP3684954C0 (en) NON-INVASIVE DIAGNOSIS OF NON-ALCOHOLIC HEPATIC STEATOSE, NON-ALCOHOLIC STEATOHEPATITIS AND/OR LIVER FIBROSIS
EP3490677A4 (en) LIPID, PROTEIN AND METABOLITE MARKER FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
EP3538135A4 (en) POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
EP3714064C0 (en) METHODS AND KITS FOR DOUBLE-STRANDED DNA AMPLIFICATION
EP3997242A4 (en) Methods of detecting disease and treatment response in cfdna
EP4011441A4 (en) Method for increasing blood flow and metabolic rate of eye fundus
ATE520032T1 (de) Differentielle cytokinexpression bei einer menschlichen krebserkrankung
IL290297A (en) Modified cytotoxic t cells and methods of use thereof
EP3740590A4 (en) LUNG CANCER DIAGNOSIS KITS AND METHODS
IL284885A (en) Method of characterization of visible and/or sub-visible particles in biologics
EP3679147C0 (en) 2-O-SULFATION ENZYME MUTANT AND 3-O-SULFATION ENZYME MUTANT, AND METHOD OF USE THEREOF
DK3417074T3 (da) Analytiske fremgangsmåder og arrays til bestemmelse af den hudsensibiliserende virkning af midler in vitro
EP3885761C0 (en) BIOSENSOR AND MEASURING METHOD USING SAME